Skip to main content

and
  1. Article

    Open Access

    Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy

    Previous studies by our group have shown that oxidative phosphorylation (OXPHOS) is the main pathway by which pancreatic cancer stem cells (CSCs) meet their energetic requirements; therefore, OXPHOS represents...

    Sonia Alcalá, Lara Villarino in Journal of Experimental & Clinical Cancer … (2024)

  2. No Access

    Article

    Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance

    Pancreatic ductal adenocarcinoma (PDAC) is an inherently chemoresistant tumor. Chemotherapy leads to apoptosis of cancer cells, and in previous studies we have shown that tumor-associated macrophage (TAM) infi...

    Gabriele D’Errico, Marta Alonso-Nocelo, Mireia Vallespinos, Patrick C. Hermann in Oncogene (2019)